Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0656
D

Failure to Care Plan Anticoagulant Therapy for a Cognitively Impaired Resident

Arlington, Texas Survey Completed on 01-29-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to develop and implement a comprehensive, person-centered care plan that included measurable objectives and interventions for a resident receiving anticoagulant therapy. Record review showed that the resident, an elderly female admitted with a primary diagnosis of cerebral infarction and additional diagnoses including dementia, sepsis, obstructive and reflux uropathy, and acute kidney failure, had a BIMs score of 3 indicating severe cognitive impairment. Medication orders reflected an active prescription for Eliquis (apixaban) 2.5 mg twice daily for clot prevention, started several months prior. However, review of the resident’s care plan, last revised on 12/20/2025, did not show any care plan addressing anticoagulant use. Interviews with facility staff confirmed that a care plan for anticoagulant medication should have been in place. The Regional RN stated there should be a care plan for anticoagulants to help staff identify adverse reactions, with interventions such as daily monitoring and CNA observation of the resident’s skin. The ADON reported she was responsible for parts of the care plan related to acute care, antibiotics, and falls, and described that staff were expected to monitor for bruising and bleeding in residents on anticoagulants as part of their tasks and morning rounds. The Administrator acknowledged that not care planning for medications like anticoagulants posed a risk that residents could receive medications they should not be getting or experience medication interactions. The facility’s Comprehensive Care Planning Policy required development and implementation of a comprehensive person-centered care plan with measurable objectives and timeframes to meet residents’ identified medical, nursing, mental, and psychosocial needs, but this was not carried out for the resident’s anticoagulant therapy.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙